BRISBANE, Calif. (AP) — BRISBANE, Calif. (AP) — CareDx Inc. (CDNA) on Wednesday reported fourth-quarter net income of $87.7 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Brisbane, California-based company said it had profit of $1.51. Earnings, adjusted for non-recurring gains, were 18 cents per share.
The molecular diagnostics company posted revenue of $86.6 million in the period.
For the year, the company reported net income of $52.5 million, or 93 cents per share, swinging to a profit in the period. Revenue was reported as $333.8 million.
CareDx expects full-year revenue in the range of $365 million to $375 million.
CareDx shares have declined slightly more than 1% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $21.10, more than doubling in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CDNA at https://www.zacks.com/ap/CDNA
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。